TAKING ON TD Trademark

Trademark Overview


On Thursday, March 7, 2024, a trademark application was filed for TAKING ON TD with the United States Patent and Trademark Office. The USPTO has given the TAKING ON TD trademark a serial number of 98438563. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 26, 2024. This trademark is owned by Neurocrine Biosciences, Inc.. The TAKING ON TD trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Promoting awareness of tardive dyskinesia; Promoting the interests of people who have tardive dyskinesia and their families and health care providers by means of public advocacy

Providing healthcare information for patients and caregivers in the field of tardive dyskinesia; Providing healthcare information for healthcare providers in the field of tardive dyskinesia; Providing medical information; Providing medical information for patients and caregivers in the field of tardive dyskinesia; Providing medical information for healthcare providers in the field of tardive dyskinesia; Online information services, namely, providing medical information in the field of tardive dyskinesia

General Information


Serial Number98438563
Word MarkTAKING ON TD
Filing DateThursday, March 7, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, November 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2024

Trademark Statements


Goods and ServicesPromoting awareness of tardive dyskinesia; Promoting the interests of people who have tardive dyskinesia and their families and health care providers by means of public advocacy
Goods and ServicesProviding healthcare information for patients and caregivers in the field of tardive dyskinesia; Providing healthcare information for healthcare providers in the field of tardive dyskinesia; Providing medical information; Providing medical information for patients and caregivers in the field of tardive dyskinesia; Providing medical information for healthcare providers in the field of tardive dyskinesia; Online information services, namely, providing medical information in the field of tardive dyskinesia

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, March 7, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 7, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Thursday, March 7, 2024NEW APPLICATION ENTERED
Sunday, July 21, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 15, 2024ASSIGNED TO EXAMINER
Wednesday, August 28, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 28, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 28, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, August 28, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 28, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, September 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 1, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT